- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 23, 2025 | 115.39M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $121.07M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $121.07M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $179.31M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $183.04M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $450.64M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $484.43M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $793.34M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $842.06M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $948.61M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $964.05M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.29B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.33B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 110.18M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $30.74M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $29.94M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.29B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.3B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $19.21M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.68M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $8.42M |
| Revenue | Q1 2025 · Mar 31, 2024 | $383.49M |